|
|
Faculty Presentations
| Dr. George Kahaly |
Fig. 01 -
Title Slide
Fig. 02 -
Disclosures
Fig. 03 -
TSH-R Antibody Assays
Fig. 04 -
Bioassays
Fig. 05 -
TRAB & TSI
Fig. 06 -
Analytical Performance
Fig. 07 -
Clinical Performance
Fig. 08 -
Comparison
Fig. 09 -
ELISA and Automated
Fig. 10 -
60 TSAb+ GD samples
Fig. 11 -
TBAb+ Hashimoto‘s samples
Fig. 12 -
Dilution Protocol
Fig. 13 -
Demographic & serological
Fig. 14 -
Untreated HG Patients
Fig. 15 -
BA Results
Fig. 16 -
TBAb Bioassay
Fig. 17 -
TSAb Bioassay Chart
Fig. 18 -
Detection
Fig. 19 -
Kronus Elisa Assay
Fig. 20 -
Summary and Conclusions
TODO, let Pete know of any updates to this content
Six (6) provocative statements concerning clinical treatment of IBD. Each statement is presented as 5 steps:Step 1: the statement & introduction, + 5 possible opinions of that statement -- please choose one
Step 2: a graph of an international survey’s opinions of that statement
Step 3: a literature review for that statement
Step 4: a graph comparing the faculty's vs an international survey’s opinions, + faculty discussion
Step 5: a brief faculty summary, plus the list of references.
Please click on any Statement or any Step tab to read this publication in the order you prefer.